15 November 2022>: Clinical Research
Suppression of Tumorigenicity 2 Pro-Inflammatory Biomarker Linking Diabetes Mellitus and Periodontitis: A Pilot Study
Paladugu Devi Navya 1CDF , Gurumoorthy Kaarthikeyan 1CEF , J. Selva Raj 2BCDE , Ahmed Alamoudi 3AEF , Maha A. Bahammam 45CEF , Bassam Zidane 6BDE , Hammam Ahmed Bahammam 7BDF , Sarah Ahmed Bahammam 8CEF , Ali Abdel-Halim Abdel-Azim Hassan 9CDE , Mona Awad Kamil 10BDE , Shilpa Bhandi 1112BEF , A. Thirumal Raj 13CEF , Shankargouda Patil 1114ACE*DOI: 10.12659/MSM.938218
Med Sci Monit 2022; 28:e938218
Table 2 Comparative analysis of levels of suppression of tumorigenicity 2 (ST2) between groups using one-way ANOVA.
Serial no. | Data | Mean±standard deviation (pg/L) | P value |
---|---|---|---|
1 | Group 1 | 252.82±87.91 | 0.000* |
Group 2 | 452.06±54.18 | ||
2 | Group 2 | 452.06±54.18 | 0.000* |
Group 3 | 558.87±68.99 | ||
3 | Group 3 | 558.87±68.99 | 0.000* |
Group 1 | 252.82±87.91 | ||
Group 1, healthy; group 2, periodontitis; group 3, periodontitis with diabetes mellitus. * |